Q4 Earnings Roundup: Addus HomeCare (NASDAQ:ADUS) And The Rest Of The Senior Health, Home Health & Hospice Segment [Yahoo! Finance]
Addus HomeCare CFO Flags Medicaid Rate Outlook, Gentiva Deal Progress, and M&A Pipeline at Conference [Yahoo! Finance]
Addus HomeCare Corporation Q4 2025 Earnings Call Summary [Yahoo! Finance]
Addus HomeCare (ADUS) had its price target lowered by Stephens from $140.00 to $135.00. They now have an "overweight" rating on the stock.
Addus HomeCare (ADUS) had its "outperform" rating reaffirmed by Royal Bank Of Canada.